lobbying_filings_raw: fcc9d2d2-eded-49bd-b9ee-616eb20c97bd
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fcc9d2d2-eded-49bd-b9ee-616eb20c97bd | Q4 | 261 | THE ADVOCACY GROUP | 100355 | EMERGENT BIOSOLUTIONS | 2015 | fourth_quarter | 2016-01-20T13:03:25.897000-05:00 | 30000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/fcc9d2d2-eded-49bd-b9ee-616eb20c97bd/", "filing_uuid": "fcc9d2d2-eded-49bd-b9ee-616eb20c97bd", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2015, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/fcc9d2d2-eded-49bd-b9ee-616eb20c97bd/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "GEORGE A. RAMONAS", "dt_posted": "2016-01-20T13:03:25.897000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1333 H. Street NW", "registrant_address_2": "Suite 500 West", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 261, "url": "https://lda.senate.gov/api/v1/registrants/261/", "house_registrant_id": 30018, "name": "THE ADVOCACY GROUP", "description": "Lobbying", "address_1": "414 3rd Street S.E.", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20003", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "GEORGE A. RAMONAS", "contact_telephone": "+1 202-255-1406", "dt_updated": "2025-07-06T00:43:13.751626-04:00"}, "client": {"id": 100355, "url": "https://lda.senate.gov/api/v1/clients/100355/", "client_id": 1698, "name": "EMERGENT BIOSOLUTIONS", "general_description": "Biopharmaceutical company focused on the commercialization of biologic products that helps the body's immune sys.", "client_government_entity": false, "client_self_select": false, "state": "MD", "state_display": "Maryland", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2009-09-01"}, "lobbying_activities": [{"general_issue_code": "DEF", "general_issue_code_display": "Defense", "description": "H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness\nS 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nH.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination\nH.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46308, "prefix": "mr", "prefix_display": "MR.", "first_name": "ROBERT", "nickname": null, "middle_name": "J", "last_name": "DOTCHIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "DIS", "general_issue_code_display": "Disaster Planning/Emergencies", "description": "H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness\nS 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nH.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination\nH.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46308, "prefix": "mr", "prefix_display": "MR.", "first_name": "ROBERT", "nickname": null, "middle_name": "J", "last_name": "DOTCHIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness\nS 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nH.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination\nH.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46308, "prefix": "mr", "prefix_display": "MR.", "first_name": "ROBERT", "nickname": null, "middle_name": "J", "last_name": "DOTCHIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HOM", "general_issue_code_display": "Homeland Security", "description": "H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nH.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness\nS 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nH.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination\nH.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46308, "prefix": "mr", "prefix_display": "MR.", "first_name": "ROBERT", "nickname": null, "middle_name": "J", "last_name": "DOTCHIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 30018 | MD | US | US | Biopharmaceutical company focused on the commercialization of biologic products that helps the body's immune sys. | 0 | 0 | 2952 | normalized_name | 0.7 |